BioNTech Results Presentation Deck

BNT162b2 selected as lead candidate for Phase 2b/3 2 SARS-COV-2 ¹ Wrapp et al., Science, 2020 19 Spike-Antigen Receptor Binding whole protein Domain (RBD) SARS-COV-2 Spike Protein 3D Structure ¹ Variant 162a1 162b1 162b2 162c2 Target RBD subunit RBD subunit 2P-mutated full spike protein 2P-mutated full spike protein Received Fast Track designation RNA construct uRNA modRNA modRNA saRNA Immunization prime/ boost prime/ boost prime/ boost single injection BIONTECH

View entire presentation